Has Mako Sather received payments from drug or device companies?

Yes. Drug and device makers reported $4,008 in general payments to Mako Sather across 156 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mako Sather did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mako Sather come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mako Sather

Nurse Practitioner · Greenwood Village, CONPI 1023223963

Payments from drug & device makers

$4,008in general payments, 2019–2025

Across 156 payments — averaging $25.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$824
Ascendis Pharma Endocrinology Inc$702
AbbVie$517
Pfizer$296
Tolmar, Inc.$262
Biomarin Pharmaceutical Inc.$205
plus $1K from 21 others

$1,915in research payments, 2019–2025

Across 4 payments — averaging $478.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novo Nordisk$2K

What the payments were for

Food & beverage$4,008100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	27	$824
Ascendis Pharma Endocrinology Inc	24	$702
AbbVie	29	$517
Pfizer	14	$296
Tolmar, Inc.	7	$262
Biomarin Pharmaceutical Inc.	9	$205
AstraZeneca	8	$174
Sanofi-aventis U.S. LLC	3	$157
Insulet Corporation	3	$149
Lilly USA, LLC	5	$79
Abbott	3	$67
Neurocrine Biosciences, Inc.	2	$64
Eton Pharmaceuticals, Inc.	2	$53
Dexcom, Inc.	2	$47
Zealand Pharma US, Inc.	1	$47
Medtronic	1	$43
Ultragenyx Pharmaceutical Inc.	2	$42
Kyowa Kirin, Inc.	2	$41
Tolmar Pharmaceuticals, Inc.	2	$41
Tandem Diabetes Care, Inc.	2	$35
BETA Bionics, Inc.	2	$32
Soleno Therapeutics, Inc.	1	$25
Endo USA, Inc.	1	$24
Xeris Pharmaceuticals, Inc.	1	$23
Endo Pharmaceuticals Inc.	1	$22
IBSA Pharma Inc.	1	$20
Azurity Pharmaceuticals, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,008 in reported general payments places this provider in the 95th percentile of 1,384 nurse practitioner providers in Colorado.

See all nurse practitioner providers in Colorado →

Other nurse practitioner in Greenwood Village

Jacob BeansGreenwood Village$4K
Rianne ClarkGreenwood Village$4K
Monica RabanalEvergreen$1.6M
Deborah HinnenColorado Springs$388K
Christina HansonLone Tree$381K
Christina ProulxDenver$222K
Kara HartPueblo$142K
Amy SidorskiAurora$97K
Lori WenzGrand Junction$54K
Lisa KeithColorado Springs$52K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →